Bill C-224: An Act to amend the Food and Drugs Act (natural health products)

This bill primarily affects manufacturers, importers, distributors, and retailers of natural health products across Canada — think vitamin and supplement companies, herbal remedy producers, health food stores, and independent wellness practitioners selling products like probiotics, herbal tinctures, or traditional remedies. These businesses, which range from small family-run operations to mid-sized manufacturers, would no longer face the heavier therapeutic product oversight requirements (such as mandatory serious adverse reaction reporting, recall powers, and associated penalties) that were layered on after the 2023 budget changes. Day-to-day activities like product labeling, record-keeping, and adverse event reporting would revert to the lighter Natural Health Products Regulations framework rather than the drug-level compliance regime. Smaller operators who may have struggled with the cost and complexity of therapeutic product compliance would see particular relief.